1Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer a woAd-wide perspective. International biological study on cervical cancer (IBSCC) study group [ J ]. J Natl Cancer Inst, 1995,87 : 796-801.
2Bosch FX, Lorincz A, Munoz N,et al.. The causal relation between human papillomavirus and cervical cancer [ J ]. Clin Pathol,2002,55 : 244-265.
3Syrjanen S,Naud P,Sarian L,et al. Up-regulation of 14-3- 3 sigma (stratifin)is associated with high-grade CIN and high-risk, human papillomavirus (HPV)at baseline but dose not predict outcomes of HR-HPV infections or incident CIN in the LAMS study [ J]. Am J Clin Pathol, 2010,133 ( 2 ) : 232 -240.
4Kang M. , Lagakos S. Evaluating the role of human papillomavirus vaccine in cervical cancer prevention [ J ]. Stat Methods Med Res,2004,13 : 139-155.
5Ohlschlager P, Quetting M. , Alvarez G, et al.. Enhancement of immunogenicity of a therapeutic cervical cancer DNA-based vaccine by co-application of sequence-optimized genetic adjuvants[ J]. Cancer,2009,125 : 189-198.
6Richardson H, Kelsall G, Tellier P, et al. The natural history of type-specific human papillomavirus infections in female university students [ J ]. Cancer Epidemiol Biomarkers Prey,2003,12:485-490.
7Ardizzone S, Cassinotti A, Trabattoni D, et al. Immunomodulatory effects of 1,25-dihydroxyvitamin D3 on TH1/ TH2 cytokines in inflammatory bowel disease:an in vitro study[ Jl Immunopathol Pharmacol,2009 ,22 :63-71.
8Avila G, Aguilar L, Romero M, et al. Cytokine response in the intestinal mucosa of hamsters infected with Taenia solium [ J ]. Ann NY Acad Sci 2008,1149 : 170-173.
9Wentzensen N, Vinokurova S, Doeberitz M. Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia [ J ]. Cancer Res ,2004,64: 3878-3884.
10Chen W, Huang L. Induction of cytotoxic T-lymphocytes and antitumor activity by a liposomal lipopeptide vaccine [ J ]. Mol Pharm,2008,5:464-471.
10Clifford GM, Rana RK, Franceschi S, et al.Human papillomavirus genotype distribution in low-grade cervical lesions:comparison by geographic region and with cervical cancer.Cancer Epidemiol Biomarkers Prev, 2005, 14(5):1157-1164.
